・Investors focused on Dexcom’s lower gross margin of 61.3%, down about 170 basis points year-over-year, despite record revenue and earnings. ・The company said elevated scrap and freight costs would ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results